Advances in Hematological Malignancies
Recent centuries have witnessed remarkable strides in the field of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering hope for more successful treatment opt